| Title : Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia - Walling_2016_Schizophr.Bull_42_335 |
| Author(s) : Walling D , Marder SR , Kane J , Fleischhacker WW , Keefe RS , Hosford DA , Dvergsten C , Segreti AC , Beaver JS , Toler SM , Jett JE , Dunbar GC |
| Ref : Schizophr Bull , 42 :335 , 2016 |
| Abstract : Walling_2016_Schizophr.Bull_42_335 |
| ESTHER : Walling_2016_Schizophr.Bull_42_335 |
| PubMedSearch : Walling_2016_Schizophr.Bull_42_335 |
| PubMedID: 26071208 |
| Title : A randomized exploratory trial of an alpha-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia - Lieberman_2013_Neuropsychopharmacology_38_968 |
| Author(s) : Lieberman JA , Dunbar G , Segreti AC , Girgis RR , Seoane F , Beaver JS , Duan N , Hosford DA |
| Ref : Neuropsychopharmacology , 38 :968 , 2013 |
| Abstract : Lieberman_2013_Neuropsychopharmacology_38_968 |
| ESTHER : Lieberman_2013_Neuropsychopharmacology_38_968 |
| PubMedSearch : Lieberman_2013_Neuropsychopharmacology_38_968 |
| PubMedID: 23303043 |